

Press Releases

Citius Announces Change To Primary Endpoint In Mino-Lok® Phase 3 Study

Sep 4, 2019

Citius Pharmaceuticals, Inc. to Present at the RHK Capital 4th annual Disruptive Growth Conference hosted by Reed Smith.

Aug 29, 2019

Citius Provides Developmental Plans for Mino-Wrap

Jul 30, 2019

Citius Pharmaceuticals' Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris

May 13, 2019

Citius Pharmaceuticals to Present at the ThinkEquity Conference

May 1, 2019

Citius Pharmaceuticals Presents Data on Mino-Lok® Showing 98% Clinical Efficacy

Apr 30, 2019

Citius Pharmaceuticals Successfully Raises $5.3 Million

Apr 4, 2019

Citius Announces $5.3 Million Registered Direct Offering Priced At-the-Market

Apr 1, 2019

Citius Pharmaceuticals to Present at NobleCon15 Investor Conference

Jan 25, 2019

Citius Licenses Mino-Wrap From MD Anderson Cancer Center

Jan 8, 2019